Low Dose Naltrexone

Low Dose Naltrexone is being developed as IRT-103/Lodonal via Immune Therapeutics, Inc.’s collaborator Cytocom, Inc. Development of IRT-103/Lodonal for Pediatric and Adult Crohn’s is currently in R&D to reach a Phase III US Trial. 

More information can be found at www.cytocom.com

  • Facebook
  • Twitter
  • LinkedIn

Immune Therapeautics, Inc. © 2017 | All Rights Reserved | 2431 Aloma Ave #124 Winter Park, FL 32792 | 1-888-613-8802